急性呼吸衰竭气管切开术后一年结局
该回顾性队列研究纳入2012至2013年加州所有医院出院、因急性呼吸衰竭接受气管切开的非手术患者共8,343例,随访至2014年。主要结局为30天、90天及1年死亡率,并统计再入院率与医疗资源利用。气管切开后1年死亡率为46.5%;65岁及以上患者死亡率54.7%,显著高于65岁以下患者的36.5%(p<0.0001),中位生存175天(95%CI 150-202天),而年轻患者超过1年(校正HR 1.25;95%CI 1.14-1.36)。1年内60.3%患者需再入院,老年患者再入院率66.1% vs 年轻患者55.2%(校正HR 1.19;95%CI 1.09-1.29)。作者认为这些发现可能有助于家庭和代理人决策。
要点
- 急性呼吸衰竭气管切开非手术患者1年死亡率为46.5%,长期结局极差。
- 65岁及以上患者1年死亡率54.7%,显著高于65岁以下患者的36.5%(p<0.0001)。
- 老年患者中位生存175天(95%CI 150-202天),年轻患者超过1年(校正HR 1.25;95%CI 1.14-1.36)。
- 气管切开后1年内60.3%患者需再入院,老年患者再入院率66.1% vs 年轻患者55.2%(校正HR 1.19;95%CI 1.09-1.29)。
- 气管切开后首年短期急性期住院总费用均值215,369美元(SD 160,874)。
适用人群与场景
- 2012至2013年加州所有医院出院、因急性呼吸衰竭接受气管切开的非手术患者,随访至2014年。
研究设计与关键结果
- 研究类型为回顾性队列研究,纳入8,343例因急性呼吸衰竭接受气管切开的非手术患者,随访至2014年。
- 主要结局1年死亡率为46.5%;65岁及以上患者54.7% vs 65岁以下患者36.5%(p<0.0001)。
- 老年患者中位生存175天(95%CI 150-202天),年轻患者超过1年(校正HR 1.25;95%CI 1.14-1.36)。
- 1年内60.3%患者需再入院;老年患者66.1% vs 年轻患者55.2%(校正HR 1.19;95%CI 1.09-1.29)。
- 首年短期急性期住院总费用(索引住院及再入院)均值215,369美元(SD 160,874)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,这些发现可能有助于家庭和代理人在气管切开决策过程中进行决策。
- 作者指出,部分年轻患者亚组可能较一般气管切开人群有更好的结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
- 另有 1 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开
OBJECTIVES: Tracheostomy utilization has dramatically increased recently. Large gaps exist between expected and actual outcomes resulting in significant decisional conflict and regret. We determined 1-year patient outcomes and healthcare utilization following tracheostomy to aid in decision-making and resource allocation.
DESIGN: Retrospective cohort study.
SETTING: All California hospital discharges from 2012 to 2013 with follow-up through 2014.
PATIENTS: Nonsurgical patients who received a tracheostomy for acute respiratory failure.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Our primary outcome was 30-day, 90-day, and 1-year mortality. We also determined hospitals readmissions rates and healthcare utilization in the first year following tracheostomy. We identified 8,343 tracheostomies during the study period. One-year mortality following tracheostomy was high, 46.5%. Older adults (≥ 65 yr) had significantly higher mortality compared with younger patients (< 65 yr) (54.7% vs 36.5%; p < 0.0001). Median survival for older adults was 175 days (95% CI, 150-202 d) compared with greater than 1 year for younger adults (adjusted hazard ratio, 1.25; 95% CI, 1.14-1.36). Within 1 year of tracheostomy, 60.3% of patients required hospital readmission. Older adults were more likely to be readmitted in the first year after tracheostomy compared with younger adults (66.1% vs 55.2%; adjusted hazard ratio, 1.19; 95% CI, 1.09-1.29). Total short-term acute care hospital costs (index and readmissions) in the first year after tracheostomy were high (mean, $215,369; SD, $160,874).
CONCLUSIONS: Long-term outcomes following tracheostomy are extremely poor with high mortality, morbidity, and healthcare resource utilization especially among older patients. Some subsets of younger patients may have better outcomes compared with the general tracheostomy population. Short-term acute care costs were extremely high in the first year following tracheostomy. If extended to the entire U.S. population, total short-term acute care hospital costs approach $11 billion dollars per year for tracheostomy-related to acute respiratory failure. These findings may aid families and surrogates in the decision-making process.
参考来源
- Mehta AB, Walkey AJ, Curran-Everett D, et al. One-Year Outcomes Following Tracheostomy for Acute Respiratory Failure. Crit Care Med. 2019. PMID: 31397716. doi:10.1097/CCM.0000000000003959
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。